Time

1
Tim e 0.2 5 0.5 0 0.7 5 1.0 0 1.2 5 1.5 0 1.7 5 2.0 0 2.2 5 2.5 0 2.7 5 3.0 0 3.2 5 % 0 10 0 0.2 5 0.5 0 0.7 5 1.0 0 1.2 5 1.5 0 1.7 5 2.0 0 2.2 5 2.5 0 2.7 5 3.0 0 3.2 5 % 0 10 0 0.2 5 0.5 0 0.7 5 1.0 0 1.2 5 1.5 0 1.7 5 2.0 0 2.2 5 2.5 0 2.7 5 3.0 0 3.2 5 % 0 10 0 MRM of 6 Channels ES+ 494.3 > 394.1 4.49 e5 2.2 3 MRM of 6 Channels ES+ 480.3 > 394.1 3.42 e4 2.2 5 2.3 3 2.3 6 2.6 3 3.0 9 MRM of 6 Channels ES+ 502.4 > 394.2 9.23 e4 2.2 1 a) Imatinib b) N-Desmethyl- Imatinib c) D8-Imatinib (IS) Suppl. Figure A :

description

MRM of 6 Channels ES+. 2.23. 494.3 > 394.1. 100. 4.49e5. %. 0. 0.25. 0.50. 0.75. 1.00. 1.25. 1.50. 1.75. 2.00. 2.25. 2.50. 2.75. 3.00. 3.25. MRM of 6 Channels ES+. 2.25. 480.3 > 394.1. 100. 3.42e4. %. 2.33. 2.36. 2.63. 3.09. 0. 0.25. 0.50. 0.75. 1.00. 1.25. 1.50. - PowerPoint PPT Presentation

Transcript of Time

Page 1: Time

Time0.25 0.50 0.75 1.00 1.25 1.50 1.75 2.00 2.25 2.50 2.75 3.00 3.25

%

0

100

0.25 0.50 0.75 1.00 1.25 1.50 1.75 2.00 2.25 2.50 2.75 3.00 3.25

%

0

100

0.25 0.50 0.75 1.00 1.25 1.50 1.75 2.00 2.25 2.50 2.75 3.00 3.25

%

0

100MRM of 6 Channels ES+

494.3 > 394.14.49e5

2.23

MRM of 6 Channels ES+ 480.3 > 394.1

3.42e42.25

2.332.36

2.63 3.09

MRM of 6 Channels ES+ 502.4 > 394.2

9.23e42.21

a) Imatinib

b) N-Desmethyl-Imatinib

c) D8-Imatinib (IS)

Suppl. Figure A :